共 30 条
- [6] A MULTI-INSTITUTIONAL ANALYSIS OF PATIENT OUTCOMES FOLLOWING INTRAVESICAL BACILLUS CALMETTE-GUERIN TREATMENT FOR NON-MUSCLE INVASIVE BLADDER CANCER JOURNAL OF UROLOGY, 2010, 183 (04): : E524 - E524
- [7] ONE-YEAR FOLLOW-UP RESULTS AFTER SEQUENTIAL INTRAVESICAL BACILLUS CALMETTE-GUERIN AND DEVICE-ASSISTED CHEMO-HYPERTHERMIA (MITOMYCIN C DELIVERED BY THE COMBAT BRS SYSTEM) FOR HIGH RISK NON-MUSCLE INVASIVE BLADDER CANCER PATIENTS ... A BACILLUS CALMETTE-GUERIN-SPARING STRATEGY JOURNAL OF UROLOGY, 2017, 197 (04): : E367 - E367
- [9] Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes JOURNAL OF UROLOGY, 2016, 195 (06): : 1697 - 1703
- [10] Re: Sequential bacillus Calmette-Guerin/Electromotive Drug Administration of Mitomycin C as the Standard Intravesical Regimen in High Risk Nonmuscle Invasive Bladder Cancer: 2-Year Outcomes JOURNAL OF UROLOGY, 2017, 197 (04): : 1173 - 1174